Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism

This publication has 62 references indexed in Scilit:

• Modulatory effect of sesamol on DOCA-salt-induced oxidative stress in uninephrectomized hypertensive rats
  Molecular and Cellular Biochemistry, 2013
• Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?
  British Journal of Pharmacology, 2012
• A new cannabinoid CB₂ receptor agonist HU‐910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
  British Journal of Pharmacology, 2011
• Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB₁) receptors in the regenerating liver
  Proceedings of the National Academy of Sciences, 2011
• Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury
  Free Radical Biology and Medicine, 2011
• Inhibitor of Fatty Acid Amide Hydrolase Normalizes Cardiovascular Function in Hypertension without Adverse Metabolic Effects
  Chemistry & Biology, 2010
• Assessment of a Spectrophotometric Assay for Monoacylglycerol Lipase Activity
  The AAPS Journal, 2010
• CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes
  Cardiovascular Research, 2009
• Heme Oxygenase-1/Carbon Monoxide
  American Journal of Respiratory Cell and Molecular Biology, 2009
• Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury
  The FASEB Journal, 2007